"What do I think about implementing lung cancer screening? It all depends on how." Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors
- PMID: 37018275
- PMCID: PMC10075440
- DOI: 10.1371/journal.pone.0283939
"What do I think about implementing lung cancer screening? It all depends on how." Acceptability and feasibility of lung cancer screening in Australia: The view of key stakeholders about health system factors
Abstract
Background: Lung cancer is the number one cause of cancer death worldwide. Although international trials demonstrate that targeted screening using low dose computed tomography (LDCT) significantly reduces lung cancer mortality, implementation of screening in the high-risk population presents complex health system challenges that need to be thoroughly understood to support policy change.
Aim: To elicit health care providers' and policymakers' views about the acceptability and feasibility of lung cancer screening (LCS) and barriers and enablers to implementation in the Australian setting.
Methods: We conducted 24 focus groups and three interviews (22 focus groups and all interviews online) in 2021 with 84 health professionals, researchers, and current cancer screening program managers and policy makers across all Australian states and territories. Focus groups included a structured presentation about lung cancer and screening and lasted approximately one hour each. A qualitative approach to analysis was used to map topics to the Consolidated Framework for Implementation Research.
Results: Nearly all participants considered LCS to be acceptable and feasible but identified a wide range of implementation challenges. Topics (five specific to health systems and five cross-cutting with participant factors) identified were mapped to CFIR constructs, of which 'readiness for implementation', 'planning' and 'executing' were most salient. Health system factor topics included delivery of the LCS program, cost, workforce considerations, quality assurance and complexity of health systems. Participants strongly advocated for streamlined referral processes. Practical strategies to address equity and access, such as using mobile screening vans, were emphasised.
Conclusions: Key stakeholders readily identified the complex challenges associated with the acceptability and feasibility of LCS in Australia. The barriers and facilitators across health system and cross-cutting topics were clearly elicited. These findings are highly relevant to the scoping of a national LCS program by the Australian Government and a subsequent recommendation for implementation.
Copyright: © 2023 Dodd et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
"Because That is the Right Thing to do": A Focus Group Study of Australian Expert Perspectives on Offering Smoking Cessation Support in Lung Cancer Screening.Nicotine Tob Res. 2025 Feb 24;27(3):387-397. doi: 10.1093/ntr/ntae215. Nicotine Tob Res. 2025. PMID: 39243356 Free PMC article.
-
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders.Transl Lung Cancer Res. 2024 Feb 29;13(2):240-255. doi: 10.21037/tlcr-23-623. Epub 2024 Feb 21. Transl Lung Cancer Res. 2024. PMID: 38496699 Free PMC article.
-
'Every Touch Point Is an Opportunity': Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program.Cancer Med. 2025 May;14(10):e70963. doi: 10.1002/cam4.70963. Cancer Med. 2025. PMID: 40387288 Free PMC article.
-
Recommendations for the implementation of a national lung cancer screening program in Portugal-A consensus statement.Pulmonology. 2024 Nov-Dec;30(6):625-635. doi: 10.1016/j.pulmoe.2024.04.003. Epub 2024 Aug 6. Pulmonology. 2024. PMID: 39112109
-
Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review.JTO Clin Res Rep. 2023 Feb 2;4(3):100469. doi: 10.1016/j.jtocrr.2023.100469. eCollection 2023 Mar. JTO Clin Res Rep. 2023. PMID: 36938372 Free PMC article.
Cited by
-
"Because That is the Right Thing to do": A Focus Group Study of Australian Expert Perspectives on Offering Smoking Cessation Support in Lung Cancer Screening.Nicotine Tob Res. 2025 Feb 24;27(3):387-397. doi: 10.1093/ntr/ntae215. Nicotine Tob Res. 2025. PMID: 39243356 Free PMC article.
-
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders.Transl Lung Cancer Res. 2024 Feb 29;13(2):240-255. doi: 10.21037/tlcr-23-623. Epub 2024 Feb 21. Transl Lung Cancer Res. 2024. PMID: 38496699 Free PMC article.
-
'Every Touch Point Is an Opportunity': Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program.Cancer Med. 2025 May;14(10):e70963. doi: 10.1002/cam4.70963. Cancer Med. 2025. PMID: 40387288 Free PMC article.
-
Developing Pre-Implementation Strategies for a Co-Designed, Technology-Assisted Parenting Intervention Using the Consolidated Framework for Implementation Research (CFIR) and Expert Recommendations for Implementing Change (ERIC) Approach.Int J Environ Res Public Health. 2024 Nov 30;21(12):1599. doi: 10.3390/ijerph21121599. Int J Environ Res Public Health. 2024. PMID: 39767440 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–917. - PubMed
-
- Australian Institute of Health and Welfare. Cancer in Australia 2017. Cancer Ser. No 101. 2017.
-
- De Koning HJ, Van Der Aalst CM, De Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020; 382: 503–13. - PubMed
-
- US Preventive Services Task Force. Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325: 962–70. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical